Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,000
Closed -$198K 1843
2025
Q4
$198K Hold
2,000
﹤0.01% 994
2025
Q3
$170K Hold
2,000
﹤0.01% 862
2025
Q2
$136K Buy
+2,000
New +$127K ﹤0.01% 1385
2023
Q1
Sell
-9,100
Closed -$731K 1665
2022
Q4
$731K Hold
9,100
0.02% 661
2022
Q3
$606K Buy
9,100
+8,900
+4,450% +$658K 0.01% 814
2022
Q2
$16K Buy
+200
New +$15.2K ﹤0.01% 1515
2020
Q2
Sell
-8,800
Closed -$645K 738
2020
Q1
$645K Buy
+8,800
New +$665K 0.03% 287

Other funds holding INCY

Centiva Capital's INCY Position: Q2 2025 in Review

Centiva Capital sold out of Incyte (INCY) in Q2 2025, closing a stake of 8,024 shares — an estimated $508K sold.

Centiva Capital first reported a position in INCY in Q4 2019 and held it in 13 quarters. The position peaked at $2.54M in Q2 2021. 658 funds tracked by Wall St. Rank hold INCY as of Q2 2025.

  • Centiva Capital reported no remaining Incyte position as of Q2 2025 after selling out during the quarter.
  • Centiva Capital sold 8,024 Incyte shares in Q2 2025, an estimated $508K.
  • Centiva Capital first reported a position in Incyte in Q4 2019 and held it in 13 quarters.
  • Centiva Capital's Incyte position peaked at $2.54M in Q2 2021.
  • 658 funds tracked by Wall St. Rank held Incyte as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.